Optimizing Efficiency in the Valve Clinic: A Review of Best Practices in Screening and Treating Severe Symptomatic Aortic Stenosis

Optimizing Efficiency in the Valve Clinic: A Review of Best Practices in Screening and Treating Severe Symptomatic Aortic Stenosis


Dale Daly, MD
Cardiovascular Disease, Interventional Cardiology
Memorial Health University Medical Center
Savannah, Georgia

Benjamin Galper, MD
Interventional Cardiology
Director, Structural Heart Disease Program
Mid-Atlantic Permanente Medical Group
McLean, Virginia

David Brian Jones, MSN, CRNP, BC
Acute Care Nurse Practitioner
Program Manager - Penn Medicine Heart Valve Services
Heart & Vascular Center at Penn
University of Pennsylvania Health System
Philadelphia, Pennsylvania


Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com


This journal-based activity is designed for interventional cardiologists, radiologists, clinical cardiologists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technologists, and other health care professionals with a special interest in the field of interventional and vascular medicine.


After participating in this activity, participants should be better able to:

  • Understand how to set up a functioning valve clinic to maximize capacity while maintaining patient care and satisfaction
  • Implement best practices, and appropriate process for screening patients within the clinic in a timely, yet effective fashion
  • Identify the best treatment approach for patients with ssAS utilizing a multispecialty heart team
claiming crediT

To be eligible for documentation of credit, participants must read the CME Supplement, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com/program/TAVR, participants may immediately download or print their documentation of credit.

Release Date: September 2, 2019
Expiration Date: September 2, 2020
Estimated time to complete: 1 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.


NACCME would like to thank the following company who has supported "Optimizing Efficiency in the Valve Clinic: A Review of Best Practices in Screening and Treating Severe Symptomatic Aortic Stenosis" through educational grants and/or in-kind support: Edwards Lifesciences


    In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


NACCME designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.00 contact hour.


NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.


Optimizing Efficiency in the Valve Clinic: A Review of Best Practices in Screening and Treating Severe Symptomatic Aortic Stenosis is approved for 1.00 ARRT Cat A Continuing Education credits as approved by The Association of Vascular & Interventional Radiographers (AVIR). Certified ID: AVIR190801

AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).


This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.


This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.


The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.


NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewer

Peter Oettgen, MD
Associate Professor of Medicine, Harvard Medical School
Director of Preventive Cardiology, Beth Israel Deaconess Medical Center
Boston, Massachusetts

Nurse planner: Susie Seaman, NP, Infectious Disease Consultants/San Diego Infusion Center, San Diego, California

Planning Committee

In addition to the faculty listed below, NACCME planners and staff include Chris Bolwell, Jennifer Ilcyn, Randy Robbin, Margaret Stefan, Colleen Waters, and Christine Welniak.

Mr. Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.


The faculty has reported the following:

Ms. Seaman: Advisory Board - Mölnlycke
Mr. Daly, Dr. Galper, Dr. Jones, and Dr. Oettgen have disclosed no relevant financial relationships with any commercial interests.


North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.


NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.